Full Year 2020 Glenmark Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q4 FY '20 Earning Conference Call of Glenmark Pharmaceuticals Limited. (Operator Instructions) Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Jason D'souza. Thank you, and over to you, sir.
' -
Thank you, moderator. Welcome to Glenmark's Q4 Earnings Call. Before I start the call, I would like to introduce the members at Glenmark. We have Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals; V. S. Mani, our Executive Director and CFO, Glenmark Pharmaceuticals; and Robert Matsuk, President, North America.
First, the review of operations for the fourth quarter ended March 31, 2020. For the fourth quarter, Glenmark's consolidated revenue was at INR 27,674 million, recording an increase of INR 796 million (sic) [7.96%]. For the year ended, Glenmark's consolidated revenue was INR 106,406.69 million (sic) [INR 106,409.69
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
